[Elsevier] Cagrilintide每semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study

anatomik Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-11-08 05:55
Reward10points

Cagrilintide每semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study[size=1em]Prof Julio Rosenstock MD a, [size=1em]Liana K Billings MD b c, Reena Gajria MD d, [size=1em]Prof Francesco Giorgino MD e, Nanna Borup Johansen MD d, Klara R Klein MD f, Usha K Thamattoor MSc g, [size=1em]Prof John B Buse MD f, Akshay B Jain MD h i j
  • The Lancet, Volume 408, Issue 10549, 4每10 July 2026, Pages 3-5











Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    1832


Return to the list